BNP Paribas Financial Markets’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$805K Sell
93,958
-101,242
-52% -$714K ﹤0.01% 3465
2026
Q1
$1.26M Buy
195,200
+38,105
+24% +$295K ﹤0.01% 2982
2025
Q4
$1.28M Sell
157,095
-15,563
-9% -$141K ﹤0.01% 2929
2025
Q3
$1.53M Buy
172,658
+125,443
+266% +$793K ﹤0.01% 2819
2025
Q2
$247K Buy
47,215
+43,607
+1,209% +$222K ﹤0.01% 3696
2025
Q1
$19.6K Sell
3,608
-3,970
-52% -$18.7K ﹤0.01% 4542
2024
Q4
$34.6K Buy
+7,578
New +$38.8K ﹤0.01% 4563
2022
Q4
Sell
-21,708
Closed -$32.6K 4092
2022
Q3
$32.6K Buy
+21,708
New +$44.6K ﹤0.01% 4054

Other funds holding AVAH

BNP Paribas Financial Markets's AVAH Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Aveanna Healthcare (AVAH) stake by 52% in Q2 2026, selling an estimated $714K and leaving 93,958 shares worth $805K. The position accounts for ﹤0.01% of the portfolio, ranked #3465.

BNP Paribas Financial Markets first reported a position in AVAH in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.53M in Q3 2025. 199 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • BNP Paribas Financial Markets held 93,958 shares of Aveanna Healthcare worth $805K as of Q2 2026.
  • BNP Paribas Financial Markets sold 101,242 Aveanna Healthcare shares in Q2 2026, an estimated $714K.
  • Aveanna Healthcare made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3465 holding.
  • BNP Paribas Financial Markets first reported a position in Aveanna Healthcare in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Aveanna Healthcare position peaked at $1.53M in Q3 2025.
  • 199 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.